• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Erich Mauff Acquires Super Voting Shares of Jushi Holdings Inc.

Share:

June 17, 2019

On June 6, 2019, Jushi Holdings Inc. (formerly, Tanzania Minerals Corp., the “Issuer”), located at 1800 NW Corporate Blvd., Suite 200, Boca Raton, FL 33431, and Jushi Inc (“Jushi”) completed its previously announced business combination (the “Business Combination”), to create a vertically integrated multi-state cannabis and hemp operator.

Erich Mauff (the “Acquiror”), President and director of the Issuer, located at 413 W. 14th St., Suite 237, New York, NY 10014, announced today that in connection with the Business Combination, the Acquiror, together with his joint actors, acquired beneficial ownership or control or direction over 20,000 Super Voting Shares (the “Acquired Securities”), which represents 13.4% of the class of Super Voting Shares.

Each Super Voting Share is entitled to 100 votes per share and is convertible into 100 Subordinate Voting Shares. The Super Voting Shares were issued in exchange for the Acquiror’s Class A Shares of Jushi. Immediately prior to the Business Combination, the Acquiror and his joint actors owned or controlled no securities of Tanzania Minerals Corp.

In connection with the acquisition, the Acquiror entered into a lock-up agreement with the agents pursuant to which such parties have agreed, subject to customary carve-outs and exceptions, that their Subordinate Voting Shares and Super Voting Shares, as applicable, and the securities convertible thereinto, or any securities issuable in exchange therefor, will be released in tranches over a period of sixteen (16) months from the date the Subordinate Voting Shares are listed on the NEO Exchange Inc.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

This press release is issued pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues, which requires a report to be filed on SEDAR (www.sedar.com) containing additional information with respect to the foregoing matters. A copy of this report may be obtained by contacting Investor Relations, Jushi Holdings Inc., investors@jushico.com, Phone: 646-859-8397.

Date: June 17, 2019

Source: MarketsInsider

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Better Therapeutics Announces $6.5M Private PlacementBetter Therapeutics Announces $6.5M Private Placement
  • Healthy.io Acquires Fellow Smartphone Urinalysis Startup Inui HealthHealthy.io Acquires Fellow Smartphone Urinalysis Startup Inui Health
  • Danaher Completes Acquisition of AbcamDanaher Completes Acquisition of Abcam
  • The Self-Driving Clinical Trial: Optimizing Research with AI and MLThe Self-Driving Clinical Trial: Optimizing Research with AI and ML
  • Infineon to acquire Cypress, strengthening and accelerating its path of profitable growthInfineon to acquire Cypress, strengthening and accelerating its path of profitable growth
  • BioNxt Signs Definitive Agreement For 100% Acquisition of IP And Co-Development of Cladribine ODF Drug Reformulation for The Treatment of Multiple SclerosisBioNxt Signs Definitive Agreement For 100% Acquisition of IP And Co-Development of Cladribine ODF Drug Reformulation for The Treatment of Multiple Sclerosis
  • Supriya Lifescience Stock Technical Analysis GuideSupriya Lifescience Stock Technical Analysis Guide
  • Fresenius Medical Care completes acquisition of NxStage MedicalFresenius Medical Care completes acquisition of NxStage Medical

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications